Linda Ameryckx

Vrije Universiteit Brussel, Bruxelles, Brussels Capital, Belgium

Are you Linda Ameryckx?

Claim your profile

Publications (6)12.95 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: To report an in vitro fertilization (IVF) pregnancy in a patient with histologically confirmed chronic endometritis before the IVF treatment without prior antibiotherapy. Case report. Academic reproductive medicine unit. A 30-year-old woman with primary infertility due to mild oligoasthenoteratospermia of the male partner. Diagnostic hysteroscopy and endometrial biopsy. Delivery after the first IVF. Histologic examination of the endometrium revealed chronic endometritis. The patient delivered a healthy boy at 40 weeks' gestation after the first IVF treatment. Our findings suggest that the impact of chronic endometritis on infertility and IVF outcome should be further investigated in prospective randomized studies.
    Fertility and sterility 02/2009; 91(4):1293.e9-11. DOI:10.1016/j.fertnstert.2008.12.050 · 4.59 Impact Factor
  • L. Ameryckx · J. J. Amy
    [Show abstract] [Hide abstract]
    ABSTRACT: Vasa praevia constitutes a rare obstetric complication that is potentially lethal for the generally healthy infant. If unrecognized antenatally, the condition carries a higher fetal mortality rate than any other complication in pregnancy. Only in the past two decades have major diagnostic advances led to a dramatic improvement of perinatal survival and lower morbidity rates. Good outcomes depend primarily on prenatal diagnosis and appropriate management. The performance of a caesarean section before rupture of the membranes and the onset of labour is mandatory. Simple modifications of standard screening protocols and the recognition of high-risk patients will allow identification of most cases of vasa praevia.
    European Clinics in Obstetrics and Gynaecology 01/2006; 2(3):128-130. DOI:10.1007/s11296-006-0040-y
  • L Ameryckx · H M Fatemi · P De Sutter · J J Amy
    [Show abstract] [Hide abstract]
    ABSTRACT: Ovarian granulosa cell tumors (GCT) are usually treated by surgery and chemotherapy. Successful response to GnRH agonists as an adjuvant therapy has previously been reported. In this case of recurrent GCT, we used a GnRH antagonist. A 78-year-old woman underwent surgery for an ovarian granulosa cell tumor (pT1a N0 Mx). Six months later, laparotomy revealed an inoperable recurrence of the tumor. Experimental treatment with a GnRH antagonist was not clearly successful. This is in contrast to the previously proven benefit of GnRH agonist therapy in this type of malignancy and to the positive response elicited by GnRH antagonists in epithelial ovarian tumors. GnRH antagonist therapy had no demonstrable efficacy in the treatment of a poorly differentiated and aggressive recurrent granulosa cell tumor.
    Gynecologic Oncology 01/2006; 99(3):764-6. DOI:10.1016/j.ygyno.2005.07.007 · 3.77 Impact Factor
  • Linda Ameryckx · M. Leunen · P. Wylock · J. J. Amy
    [Show abstract] [Hide abstract]
    ABSTRACT: Paediatric breast disorders represent a varied set of abnormalities. The bulk of breast pathology in children and adolescents consists of congenital and developmental anomalies, infections and tumours of which most are benign. As breast development represents an important, early manifestation of female sexuality, inadequate development often constitutes a major worry for the adolescent and her parents. We briefly discuss the normal embryologic and physiologic aspects of breast development, which will serve as an introduction to the congenital and developmental problems seen in young girls and adolescents.
    European Clinics in Obstetrics and Gynaecology 12/2005; 1(3):151-163. DOI:10.1007/s11296-005-0009-2
  • Fertility and Sterility 09/2001; 76(3). DOI:10.1016/S0015-0282(01)02546-8 · 4.59 Impact Factor

Publication Stats

23 Citations
12.95 Total Impact Points


  • 2006–2009
    • Vrije Universiteit Brussel
      • Department of Obstetrics and Gynecology
      Bruxelles, Brussels Capital, Belgium
    • Homerton University Hospital NHS Foundation Trust
      Londinium, England, United Kingdom